Caesarean section · women with gestational diabetes mellitus
Lifestyle interventions showed no clear difference in caesarean section compared with control ‐ Maternal outcomes (low certainty).
1 finding from 1 review
Induction of labour · women with gestational diabetes mellitus
Lifestyle interventions showed no clear difference in induction of labour compared with control ‐ Maternal outcomes (high certainty).
1 finding from 1 review
Postnatal depression · women with gestational diabetes mellitus
Lifestyle interventions may leads to lower postnatal depression compared with control ‐ Maternal outcomes (low certainty).
1 finding from 1 review
Postnatal weight retention or return to pre‐pregnancy weight · women with gestational diabetes mellitus
Lifestyle interventions may leads to higher postnatal weight retention or return to pre‐pregnancy weight compared with control ‐ Maternal outcomes (low certainty).
1 finding from 1 review
Development of type 2 diabetes · women with gestational diabetes mellitus
Lifestyle interventions showed no clear difference in development of type 2 diabetes ( compared with control ‐ Maternal outcomes (low certainty).
1 finding from 1 review
Large‐for‐gestational age · women with gestational diabetes mellitus
Lifestyle probably leads to lower large‐for‐gestational age compared with control ‐ Neonatal and later outcomes (moderate certainty).
1 finding from 1 review
Perinatal (fetal and neonatal death) and later infant mortality · women with gestational diabetes mellitus
Lifestyle showed no clear difference in perinatal (fetal and neonatal death) and later infant mortality compared with control ‐ Neonatal and later outcomes (low certainty).
1 finding from 1 review
Satisfaction with pain relief · women in labour with planned vaginal delivery
1 finding from 1 review
Additional analgesia required (escape analgesia) · women in labour with planned vaginal delivery
Remifentanil (PCA) showed no clear difference in additional analgesia required (escape analgesia) compared with another opioid (PCA) (low certainty).
1 finding from 1 review
Caesarean section · women in labour with planned vaginal delivery
It is very uncertain whether remifentanil (PCA) changes rate of caesarean delivery compared with another opioid (PCA) (very low certainty).
1 finding from 1 review
Maternal apnoea · women in labour with planned vaginal delivery
1 finding from 1 review
Maternal respiratory depression (< 8 breaths/min) · women in labour with planned vaginal delivery
1 finding from 1 review
Low Apgar score · women in labour with planned vaginal delivery
1 finding from 1 review
Satisfaction with pain relief · women in labour with planned vaginal delivery
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · women in labour with planned vaginal delivery
1 finding from 1 review
Additional analgesia required (escape analgesia) · women in labour with planned vaginal delivery
Remifentanil (PCA) probably leads to higher additional analgesia required compared with epidural/CSE (moderate certainty).
1 finding from 1 review
Caesarean section · women in labour with planned vaginal delivery
Remifentanil (PCA) showed no clear difference in rate of caesarean delivery compared with epidural/CSE (moderate certainty).
1 finding from 1 review
Maternal apnoea · women in labour with planned vaginal delivery
1 finding from 1 review
Pain intensity VAS (0 to 100; 0 = no pain, 100 = worst pain) · women in labour with planned vaginal delivery
1 finding from 1 review
Maternal respiratory depression (< 9, < 8 breaths/min) · women in labour with planned vaginal delivery
Remifentanil (PCA) showed no clear difference in maternal respiratory depression (< 9, < 8 breaths/min) compared with epidural/CSE (low certainty).
1 finding from 1 review